These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 1834112)

  • 1. Serological and molecular evidence of infection by human T-cell lymphotropic virus type II in Italian drug addicts by use of synthetic peptides and polymerase chain reaction.
    De Rossi A; Mammano F; Del Mistro A; Chieco-Bianchi L
    Eur J Cancer; 1991; 27(7):835-8. PubMed ID: 1834112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans.
    Lee H; Swanson P; Shorty VS; Zack JA; Rosenblatt JD; Chen IS
    Science; 1989 Apr; 244(4903):471-5. PubMed ID: 2655084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTLV infection among Italian intravenous drug users and North African subjects detected by the polymerase chain reaction and serological methods.
    Colombo E; Magistrelli C; Mendozzi E; Cattaneo E; Achilli G; Ferrante P
    J Med Virol; 1995 Sep; 47(1):10-5. PubMed ID: 8551251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
    Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
    Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T lymphotropic virus (HTLV) type I and II DNA amplification in HTLV-I/II-seropositive blood donors of the French West Indies.
    Wattel E; Mariotti M; Agis F; Gordien E; Prou O; Courouce AM; Rouger P; Wain-Hobson S; Chen IS; Lefrère JJ
    J Infect Dis; 1992 Feb; 165(2):369-72. PubMed ID: 1730903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
    Mangano AM; Remesar M; del Pozo A; Sen L
    J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difficulties in the diagnosis of HTLV-2 infection in HIV/AIDS patients from Brazil: comparative performances of serologic and molecular assays, and detection of HTLV-2b subtype.
    Morimoto HK; Morimoto AA; Reiche EM; Ueda LT; Matsuo T; Reiche FV; Caterino-de-Araujo A
    Rev Inst Med Trop Sao Paulo; 2007; 49(4):225-30. PubMed ID: 17823751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type- and group-specific continuous antigenic determinants of HTLV. Use of synthetic peptides for serotyping of HTLV-I and -II infection.
    Blomberg J; Robert-Guroff M; Blattner WA; Pipkorn R
    J Acquir Immune Defic Syndr (1988); 1992; 5(3):294-302. PubMed ID: 1371319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serologic differentiation of human T lymphotropic virus type I from type II infection by synthetic peptide immunoassays.
    Roberts CR; Mitra R; Hyams K; Brodine SK; Lal RB
    J Med Virol; 1992 Apr; 36(4):298-302. PubMed ID: 1578221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins.
    Varma M; Rudolph DL; Knuchel M; Switzer WM; Hadlock KG; Velligan M; Chan L; Foung SK; Lal RB
    J Clin Microbiol; 1995 Dec; 33(12):3239-44. PubMed ID: 8586709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Typing human T-cell lymphotropic virus (HTLV-I and HTLV-II) by nested polymerase chain reaction: application to clinical specimens.
    Vallejo A; García-Sáiz A
    J Virol Methods; 1995 Jan; 51(1):9-17. PubMed ID: 7730441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological speciation of human T-cell leukaemia virus infections using synthetic peptide antigens.
    Tosswill JH; McAlpine L; Mortimer PP
    J Med Virol; 1993 May; 40(1):83-5. PubMed ID: 8099946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence, risk factors and genetic characterization of human T-cell lymphotropic virus types 1 and 2 in patients infected with human immunodeficiency virus type 1 in the cities of Ribeirão Preto and São Paulo].
    Kleine Neto W; Sanabani SS; Jamal LF; Sabino EC
    Rev Soc Bras Med Trop; 2009; 42(3):264-70. PubMed ID: 19684973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Confirmation of the presence in Cuba of human T-cell lymphotropic virus type I using the polymerase chain reaction].
    Rolo Gómez F; De Armas MB; Mato Luis J; Lubián Caballero AL; Díaz Torres H
    Rev Cubana Med Trop; 1997; 49(3):204-8. PubMed ID: 9685988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HTLV-I and HTLV-II infections in hematologic disorder patients, cancer patients, and healthy individuals from Rio de Janeiro, Brazil.
    Farias de Carvalho SM; Pombo de Oliveira MS; Thuler LC; Rios M; Coelho RC; Rubim LC; Silva EM; Reis AM; Catovsky D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jul; 15(3):238-42. PubMed ID: 9257659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human T-cell lymphotropic virus types I and II infections in patients with leukaemia/lymphoma and in subjects with sexually transmitted diseases in Nigeria.
    Olaleye OD; Ekweozor CC; Li ZL; Opala IE; Sheng Z; Onyemenem TN; Rasheed S
    Arch Virol; 1996; 141(2):345-55. PubMed ID: 8634025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No evidence for human T-cell leukemia virus type I or human T-cell leukemia virus type II infection in patients with multiple sclerosis.
    Perl A; Nagy K; Pazmany T; Isaacs C; Baraczka K; Szabo T; Feher J
    Arch Neurol; 1990 Oct; 47(10):1061-3. PubMed ID: 2222235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-II.
    Bonis J; Baillou A; Barin F; Verdier M; Janvier B; Denis F
    J Clin Microbiol; 1993 Jun; 31(6):1481-5. PubMed ID: 8314990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified Western blot assay for confirmation and differentiation of human T cell lymphotropic virus types I and II.
    Lipka JJ; Santiago P; Chan L; Reyes GR; Samuel KP; Blattner WA; Shaw GM; Hanson CV; Sninsky JJ; Foung SK
    J Infect Dis; 1991 Aug; 164(2):400-3. PubMed ID: 1856487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitive and specific polymerase chain reaction assays for diagnosis of human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections in HTLV-I/II-seropositive individuals.
    Heneine W; Khabbaz RF; Lal RB; Kaplan JE
    J Clin Microbiol; 1992 Jun; 30(6):1605-7. PubMed ID: 1624585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.